{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:18:41Z","timestamp":1790997521717,"version":"4.1.0"},"reference-count":107,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,11,28]]},"DOI":"10.3233\/jad-170490","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T11:22:16Z","timestamp":1510658536000},"page":"265-281","source":"Crossref","is-referenced-by-count":118,"title":["Cognitive Decline in Preclinical Alzheimer\u2019s Disease: Amyloid-Beta versus Tauopathy"],"prefix":"10.1177","volume":"61","author":[{"given":"Colin M.","family":"Huber","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA"},{"name":"Department of Bioengineering, University of Pennsylvania School of Engineering and Applied Sciences, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Yee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"May","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Dhanala","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie S.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170490_ref1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","article-title":"Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice: Correlations with plaques, tangles, and oligomeric species","volume":"74","author":"Lopez-Gonzalez","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-170490_ref2","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-170490_ref3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: A possible link between beta amyloid peptide and tau protein","volume":"223","author":"Hernandez","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-170490_ref4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170490_ref5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-170490_ref6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/NEN.0b013e318217a118","article-title":"Brain oligomeric beta-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein\/tau transgenic mice","volume":"70","author":"DaRocha-Souto","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-170490_ref7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","article-title":"Amyloid oligomers: Formation and toxicity of Abeta oligomers","volume":"277","author":"Sakono","year":"2010","journal-title":"FEBS J"},{"key":"10.3233\/JAD-170490_ref8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.3233\/JAD-170490_ref9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","article-title":"Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome","volume":"43","author":"Oddo","year":"2004","journal-title":"Neuron"},{"key":"10.3233\/JAD-170490_ref10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JAD-170490_ref11","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1523\/JNEUROSCI.4989-14.2015","article-title":"Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer\u2019s disease mouse model","volume":"35","author":"Castillo-Carranza","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170490_ref12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.3233\/JAD-170490_ref13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"10.3233\/JAD-170490_ref14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/13543784.2016.1216972","article-title":"Old and new acetylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"25","author":"Galimberti","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-170490_ref15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-142208","article-title":"Systematic review of the relationship between amyloid-beta levels and measures of transgenic mouse cognitive deficit in Alzheimer\u2019s disease","volume":"44","author":"Foley","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170490_ref16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"issue":"Suppl 2","key":"10.3233\/JAD-170490_ref17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2011-110161","article-title":"Tau transgenic mice as models for cerebrospinal fluid tau biomarkers","volume":"24","author":"Barten","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170490_ref18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref19","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau","volume":"28","author":"Green","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170490_ref20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D\u2019Hooge","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"10.3233\/JAD-170490_ref21","first-page":"A56","article-title":"Undergraduate biocuration: Developing tomorrow\u2019s researchers while mining today\u2019s data","volume":"14","author":"Mitchell","year":"2015","journal-title":"J Undergrad Neurosci Educ"},{"key":"10.3233\/JAD-170490_ref22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2202-9-81","article-title":"Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer\u2019s disease-related pathologies in male triple-transgenic mice","volume":"9","author":"Mastrangelo","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-170490_ref23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.3233\/JAD-170490_ref24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-170490_ref25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: Procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-170490_ref26","first-page":"e52706","article-title":"Morris water maze test: Optimization for mouse strain and testing environment","author":"Weitzner","year":"2015","journal-title":"J Vis Exp"},{"key":"10.3233\/JAD-170490_ref27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1460-9568.1990.tb00014.x","article-title":"Ibotenate lesions of hippocampus and\/or subiculum: Dissociating components of allocentric spatial learning","volume":"2","author":"Morris","year":"1990","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-170490_ref28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.lfs.2010.09.004","article-title":"Assessment of spatial memory in mice","volume":"87","author":"Sharma","year":"2010","journal-title":"Life Sci"},{"key":"10.3233\/JAD-170490_ref29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.physbeh.2013.04.001","article-title":"Effects of pretraining and water temperature on female rats\u2019 performance in the Morris water maze","volume":"122","author":"Anderson","year":"2013","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-170490_ref30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: Neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn Process"},{"key":"10.3233\/JAD-170490_ref31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0301-0082(98)00085-9","article-title":"Global ischemia and behavioural deficits","volume":"58","author":"Block","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-170490_ref32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ajpath.2011.04.041","article-title":"Loss of muscarinic M1 receptor exacerbates Alzheimer\u2019s disease-like pathology and cognitive decline","volume":"179","author":"Medeiros","year":"2011","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-170490_ref33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer\u2019s disease and neuronal loss","volume":"25","author":"Ager","year":"2015","journal-title":"Hippocampus"},{"key":"10.3233\/JAD-170490_ref34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/jnc.13195","article-title":"Short-term modern life-like stress exacerbates Abeta-pathology and synapse loss in 3xTg-AD mice","volume":"134","author":"Baglietto-Vargas","year":"2015","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170490_ref35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2013.10.019","article-title":"Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition","volume":"62","author":"Baglietto-Vargas","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-170490_ref36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.biopsych.2012.12.003","article-title":"Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology","volume":"74","author":"Baglietto-Vargas","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-170490_ref37","doi-asserted-by":"crossref","first-page":"e78554","DOI":"10.1371\/journal.pone.0078554","article-title":"Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: Implications for Alzheimer\u2019s disease","volume":"8","author":"Barron","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-010-0734-6","article-title":"Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Abeta and tau pathologies in 3xTg-AD mice","volume":"120","author":"Blanchard","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170490_ref39","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-170490_ref40","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1038\/cddis.2013.139","article-title":"Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals","volume":"4","author":"Bomba","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.3233\/JAD-170490_ref41","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2014.06.011","article-title":"Administration of a selective beta2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Branca","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref42","doi-asserted-by":"crossref","first-page":"e21660","DOI":"10.1371\/journal.pone.0021660","article-title":"Amitriptyline-mediated cognitive enhancement in aged 3xTg Alzheimer\u2019s disease mice is associated with neurogenesis and neurotrophic activity","volume":"6","author":"Chadwick","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12035-013-8539-y","article-title":"Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice","volume":"49","author":"Chen","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-170490_ref44","doi-asserted-by":"crossref","first-page":"e17971","DOI":"10.1371\/journal.pone.0017971","article-title":"Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice","volume":"6","author":"Corona","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref45","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1038\/cddis.2010.73","article-title":"Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction","volume":"1","author":"Corona","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.3233\/JAD-170490_ref46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12974-015-0366-9","article-title":"Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice","volume":"12","author":"Dagher","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-170490_ref47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","article-title":"Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies","volume":"122","author":"Dai","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-170490_ref48","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.neurobiolaging.2014.02.011","article-title":"Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer\u2019s disease with plaques and tangles","volume":"35","author":"Di Meco","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000440864","article-title":"AF710B, a novel M1\/sigma1 agonist with therapeutic efficacy in animal models of Alzheimer\u2019s disease","volume":"16","author":"Fisher","year":"2016","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-170490_ref50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2013.08.030","article-title":"Melanocortins protect against progression of Alzheimer\u2019s disease in triple-transgenic mice by targeting multiple pathophysiological pathways","volume":"35","author":"Giuliani","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nlm.2013.05.006","article-title":"Hydrogen sulfide slows down progression of experimental Alzheimer\u2019s disease by targeting multiple pathophysiological mechanisms","volume":"104","author":"Giuliani","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-170490_ref52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.22325","article-title":"ST101 induces a novel 17 kDa APP cleavage that precludes Abeta generation in vivo","volume":"69","author":"Green","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170490_ref53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2006.12.019","article-title":"Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer\u2019s disease","volume":"26","author":"Halagappa","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-170490_ref54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuro.2016.02.012","article-title":"Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice","volume":"53","author":"Hu","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.3233\/JAD-170490_ref55","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer\u2019s disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J Immunol"},{"key":"10.3233\/JAD-170490_ref56","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2014.02.010","article-title":"High-fat diet-induced memory impairment in triple-transgenic Alzheimer\u2019s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology","volume":"35","author":"Knight","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref57","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/7854_2012_237","article-title":"Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer\u2019s disease","volume":"15","author":"Marlatt","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"10.3233\/JAD-170490_ref59","doi-asserted-by":"crossref","first-page":"e99226","DOI":"10.1371\/journal.pone.0099226","article-title":"Maternal high-fat diet worsens memory deficits in the triple-transgenic (3xTgAD) mouse model of Alzheimer\u2019s disease","volume":"9","author":"Martin","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref60","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer\u2019s-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-170490_ref61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajpath.2013.10.010","article-title":"alpha7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles","volume":"184","author":"Medeiros","year":"2014","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-170490_ref62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1750-3639.2010.00430.x","article-title":"Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity","volume":"21","author":"Medina","year":"2011","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-170490_ref63","doi-asserted-by":"crossref","first-page":"e2124","DOI":"10.1371\/journal.pone.0002124","article-title":"Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy","volume":"3","author":"Movsesyan","year":"2008","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jnc.12706","article-title":"Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice","volume":"130","author":"Palm","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170490_ref65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3233\/JAD-2010-100204","article-title":"Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation","volume":"21","author":"Parachikova","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170490_ref66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/acel.12049","article-title":"Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer\u2019s disease mouse model","volume":"12","author":"Parrella","year":"2013","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-170490_ref67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","article-title":"Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice","volume":"516","author":"Peng","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-170490_ref68","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s12035-013-8478-7","article-title":"Nonhuman amyloid oligomer epitope reduces Alzheimer\u2019s-like neuropathology in 3xTg-AD transgenic mice","volume":"48","author":"Rasool","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-170490_ref69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jnc.12305","article-title":"Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Abeta deposition and tau pathology in 3xTg-AD mice","volume":"126","author":"Rasool","year":"2013","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170490_ref70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000336427","article-title":"Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer\u2019s disease in triple transgenic mice (3xTg-AD)","volume":"11","author":"Ratia","year":"2013","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-170490_ref71","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/cns.12312","article-title":"Lenti-GDNF gene therapy protects against Alzheimer\u2019s disease-like neuropathology in 3xTg-AD mice and MC65 cells","volume":"20","author":"Revilla","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-170490_ref72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","article-title":"The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice","volume":"93","author":"Sabogal-Guaqueta","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-170490_ref73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuropharm.2015.11.002","article-title":"Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer\u2019s mice","volume":"102","author":"Sabogal-Guaqueta","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-170490_ref74","doi-asserted-by":"crossref","first-page":"e0145467","DOI":"10.1371\/journal.pone.0145467","article-title":"Role of liver X receptor in AD pathophysiology","volume":"10","author":"Sandoval-Hernandez","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170490_ref75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12031-015-0665-8","article-title":"Liver X receptor agonist modifies the DNA methylation profile of synapse and neurogenesis-related genes in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"58","author":"Sandoval-Hernandez","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-170490_ref76","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.neurobiolaging.2013.10.091","article-title":"Neuropep-1 ameliorates learning and memory deficits in an Alzheimer\u2019s disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques","volume":"35","author":"Shin","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.expneurol.2012.10.005","article-title":"Mercaptoacetamide-based class II HDAC inhibitor lowers Abeta levels and improves learning and memory in a mouse model of Alzheimer\u2019s disease","volume":"239","author":"Sung","year":"2013","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-170490_ref78","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-170490_ref79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-9-106","article-title":"Tumor necrosis factor-alpha synthesis inhibitor 3,6\u2019-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease","volume":"9","author":"Tweedie","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-170490_ref80","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/WAD.0000000000000075","article-title":"Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice","volume":"29","author":"Wu","year":"2015","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-170490_ref81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00702-014-1294-z","article-title":"Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice","volume":"122","author":"Yu","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-170490_ref82","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.neurobiolaging.2015.04.005","article-title":"Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Zumkehr","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170490_ref83","doi-asserted-by":"crossref","first-page":"19014","DOI":"10.1073\/pnas.1013543107","article-title":"Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-170490_ref84","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jnr.22387","article-title":"Impaired neurogenesis is an early event in the etiology of familial Alzheimer\u2019s disease in transgenic mice","volume":"88","author":"Demars","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-170490_ref85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"Olsson","year":"2005","journal-title":"Clin Chem"},{"key":"10.3233\/JAD-170490_ref86","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2174\/13816128113199990498","article-title":"The effects of soluble Abeta oligomers on neurodegeneration in Alzheimer\u2019s disease","volume":"20","author":"Brouillette","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-170490_ref87","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1523\/JNEUROSCI.5901-11.2012","article-title":"Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-beta1-42 oligomers are revealed in vivo by using a novel animal model","volume":"32","author":"Brouillette","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170490_ref88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-170490_ref89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-170490_ref90","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1091\/mbc.3.10.1141","article-title":"Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau","volume":"3","author":"Drechsel","year":"1992","journal-title":"Mol Biol Cell"},{"key":"10.3233\/JAD-170490_ref91","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1073\/pnas.73.11.4070","article-title":"Tubulin requires tau for growth onto microtubule initiating sites","volume":"73","author":"Witman","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-170490_ref92","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170490_ref93","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170490_ref94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnmol.2011.00017","article-title":"GSK3 and Alzheimer\u2019s Disease: Facts and Fiction","volume":"4","author":"Kremer","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-170490_ref95","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/jnr.23576","article-title":"Cyclin-dependent kinase 5 targeting prevents beta-Amyloid aggregation involving glycogen synthase kinase 3beta and phosphatases","volume":"93","author":"Castro-Alvarez","year":"2015","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-170490_ref96","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1523\/JNEUROSCI.5245-07.2008","article-title":"Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing","volume":"28","author":"Wen","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170490_ref97","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1471-4159.2009.05882.x","article-title":"Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases","volume":"108","author":"Yu","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170490_ref98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000433581","article-title":"An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies","volume":"15","author":"Coan","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-170490_ref99","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1089\/neu.2008.0658","article-title":"Pathology dynamics predict spinal cord injury therapeutic success","volume":"25","author":"Mitchell","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.3233\/JAD-170490_ref100","unstructured":"Mitchell CS , Lee RH (2012) Dynamic meta-analysis as a therapeutic prediction tool for amyotrophic lateral sclerosis. In Amyotrophic Lateral Sclerosis, http:\/\/www.intechopen.com\/books\/amyotrophic-lateral-sclerosis\/dynamic-meta-analysis-as-a-therapeutic-prediction-tool-for-amyotrophic-lateral-sclerosis"},{"key":"10.3233\/JAD-170490_ref101","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fncel.2015.00248","article-title":"Seeking homeostasis: Temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice","volume":"9","author":"Irvin","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-170490_ref102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/21678421.2015.1047455","article-title":"State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model","volume":"17","author":"Kim","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.3233\/JAD-170490_ref103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000369812","article-title":"Antecedent disease is less prevalent in amyotrophic lateral sclerosis","volume":"15","author":"Mitchell","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-170490_ref104","first-page":"595","article-title":"The role of tau kinases in Alzheimer\u2019s disease","volume":"13","author":"Dolan","year":"2010","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.3233\/JAD-170490_ref105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-170490_ref106","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","article-title":"Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta","volume":"74","author":"Reynolds","year":"2000","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170490_ref107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","article-title":"Protein phosphorylation in neurodegeneration: Friend or foe?","volume":"7","author":"Tenreiro","year":"2014","journal-title":"Front Mol Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:14Z","timestamp":1777370714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":107,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-170490","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}